Aldeyra Therapeutics, Inc. (ALDX) Stock Profile — Insider Trades & Financials

Net Income-$6.5M

EPS$-0.56

Market Cap$91.8M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Todd Brady

CEO & Executive Director

Company profile for Aldeyra Therapeutics, Inc. (ALDX) stock, with a description, list of executives, contact details and other key facts.

Founded: 2004
Employees: 1
Headquarters: Lexington, MA, United States
Website: aldeyra.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-14.60%

ROA?

-8.97%

D/E Ratio?

0.63

📊

Profitability Ratios

Current Ratio?

2.58

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 1, 2026 (in 116 days)

Annual Report (10-K) — Based on filing pattern

Aug 1, 2026

Predicted10-K

Feb 27, 2026

10-KQ4 20250d after period end

Feb 27, 2026

10-KFY 202558d after period end

Nov 5, 2025

10-QQ3 20258d after period end

Aug 7, 2025

10-QQ2 20252d after period end

May 14, 2025

10-QQ1 20252d after period end

Mar 28, 2025

10-K/AQ4 202430d after period end

Feb 28, 2025

10-KFY 202559d after period end

Nov 7, 2024

10-QQ3 20242d after period end

Loading company sections...

Aldeyra Therapeutics, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness